Skip to main navigation Skip to search Skip to main content

CTU: A PHASE III, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF INDUCTION THERAPY WITH RO7790121 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

  • Leong, Rupert (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Quinlan, Gabriel (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)
  • McHugh, Tracey (Clinical Trial Unit Staff)
  • Garcia, Michelle (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleGA45332
AcronymSIBERITE-2
StatusActive
Effective start/end date19/02/25 → 31/10/29